L462 (Deferasirox (for Oral Suspension) 250 mg)
Pill with imprint L462 is White, Round and has been identified as Deferasirox (for Oral Suspension) 250 mg. It is supplied by Alembic Pharmaceuticals Inc..
Deferasirox is used in the treatment of iron overload; thalassemia; hemosiderosis and belongs to the drug class chelating agents. Risk cannot be ruled out during pregnancy. Deferasirox 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for L462
Deferasirox (for Oral Suspension)
- Imprint
- L462
- Strength
- 250 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Chelating agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Alembic Pharmaceuticals Inc.
- National Drug Code (NDC)
- 62332-0325
Related Images for "L462"
More about deferasirox
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 3 Reviews
- Drug class: chelating agents
Consumer resources
- Patient Information
- Deferasirox (Advanced Reading)
- Deferasirox Tablets For Oral Suspension
- Deferasirox Sprinkle Granules
- Deferasirox Tablets
- Other brands
- Jadenu, Exjade, Jadenu Sprinkle
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.